These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects. Lee MH, Bae SK, Kim EJ, Kim YG, Kim SO, Lee DH, Lim H, Yoo SE, Lee MG. J Pharm Sci; 2003 Jan; 92(1):190-201. PubMed ID: 12486695 [Abstract] [Full Text] [Related]
4. Effect of EM574 on postprandial pancreaticobiliary secretion, gastric motor activity, and emptying in conscious dogs. Tanaka T, Mizumoto A, Mochiki E, Suzuki H, Itoh Z, Omura S. Dig Dis Sci; 1999 Jun; 44(6):1100-6. PubMed ID: 10389679 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects. Shim HJ, Kim YC, Park KJ, Kim DS, Kwon JW, Kim WB, Lee MG. J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504 [Abstract] [Full Text] [Related]
10. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects. Kim SH, Lee MG. Life Sci; 2002 Feb 01; 70(11):1299-315. PubMed ID: 11883708 [Abstract] [Full Text] [Related]
11. Presystemic and systemic intestinal metabolism of fenoterol in the conscious rat. Koster AS, Hofman GA, Frankhuijzen-Sierevogel AC, Noordhoek J. Drug Metab Dispos; 1985 Feb 01; 13(4):464-70. PubMed ID: 2863112 [Abstract] [Full Text] [Related]
15. Studies on the first-pass metabolism of ebastine in rats. Fujii T, Matsumoto S, Hatoyama T, Miyazaki H. Arzneimittelforschung; 1997 Aug 01; 47(8):949-53. PubMed ID: 9296281 [Abstract] [Full Text] [Related]
16. First-pass effect of norethindrone in rabbits and rats. Back DJ, Breckenridge AM, Crawford FE, Orme ML, Rowe PH, Smith E. J Pharmacol Exp Ther; 1978 Nov 01; 207(2):555-65. PubMed ID: 712638 [Abstract] [Full Text] [Related]
17. In situ studies of regional absorption of lobucavir and ganciclovir from rabbit intestine and predictions of dose-limited absorption and associated variability in humans. Yang Z, Manitpisitkul P, Sawchuk RJ. J Pharm Sci; 2006 Oct 01; 95(10):2276-92. PubMed ID: 16883564 [Abstract] [Full Text] [Related]
18. Evaluation of drug absorption and presystemic metabolism using an in situ intestinal preparation. Yorgey KA, Pritchard JF, Renzi NL, Dvorchik BH. J Pharm Sci; 1986 Sep 01; 75(9):869-72. PubMed ID: 3783453 [Abstract] [Full Text] [Related]
19. Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique. von Richter O, Greiner B, Fromm MF, Fraser R, Omari T, Barclay ML, Dent J, Somogyi AA, Eichelbaum M. Clin Pharmacol Ther; 2001 Sep 01; 70(3):217-27. PubMed ID: 11557909 [Abstract] [Full Text] [Related]
20. Lanreotide effect on splanchnic blood flow in healthy subjects: effect of the rate of infusion. Sieber CC, Beglinger C, Bart S, Tschoepl M, Currie G, Larsen F, Drewe J. Clin Pharmacol Ther; 2004 Jan 01; 75(1):70-9. PubMed ID: 14749693 [Abstract] [Full Text] [Related] Page: [Next] [New Search]